Skip to content
The Inflation Reduction Act (IRA) includes a misguided plan to control prices that will only result in costlier medicine and reduced access, lawmakers and […]
Why drug price controls ‘risk the future of investment’ in R&D Read More »
September 15 marks the start of Hispanic Heritage Month, an annual reminder and chance to honor the countless contributions made by members of the
In an effort to speed drug development, the Food and Drug Administration (FDA) often allows the use of biomarkers to help prove whether new
Explainer: What are biomarkers? Read More »
New rules for applying for federal SBIR/STTR seed funding will be explained by members of the NIH office reviewing applications in a Sept. 19
BIO webinar offers expert advice on applications for SBIR/STTR grants Read More »
People six months and older should have one of the updated COVID-19 vaccines released by Pfizer-BioNTech and Moderna, under the recommendation approved Sept. 12
CDC recommends everyone get the updated COVID-19 vaccines Read More »
The U.S. Food and Drug Administration (FDA) on Sept. 11 approved updated Pfizer-BioNTech and Moderna vaccines for people over 12. In addition, FDA authorized
FDA approves updated COVID vaccines Read More »
Kintara Therapeutics, Biotechnology Innovation Organization (BIO) member, is an innovative, patient-centered biotech company that is working to change the game when it comes to
Kintara Q&A: novel treatments for aggressive cancers Read More »
The Sept. 9-10 G20 summit put a spotlight on India’s economy, which stands out for its rapid growth in biotech, particularly in the state
Producing a third of the world’s vaccines, Telangana supports India’s biotech boom Read More »
Antimicrobial resistance (AMR) continues to raise concerns among the medical and scientific community. But, AMR could be combatted in part with vaccines, said experts
AMR vaccines might be a new tool to fight this global health threat Read More »
Rachel King, the CEO of the Biotechnology Innovation Organization (BIO), shares insights about drug price controls and other challenges to the biotech industry that
BIO’s Rachel King weighs in on IRA and the biotech industry in new podcasts Read More »
